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Abstract—Monitoring of patient response to the anaesthetic
drugs is an attractive improvement for achieving a correct bal-
ance of sedation level, increasing the chance of success in the right
procedure of anaesthesia. Nowadays, there are no commercial
tools able to offer real-time monitoring of anaesthetics, indeed,
there is still a lack in sensing technologies able to maintain
high performances in long term monitoring within a portable
miniaturised hardware system. To overcome these limitations,
we are here presenting the innovative concept of a portable
pen-device able to sense anaesthetic compounds over time. This
study is based on an electrochemical sensor to be fully integrated
into a complete pen-shaped point-of-care for the monitoring
of anaesthesia delivery. The design of the system is based on
a bio-inspired event-based approach that is guaranteeing low
complexity, low power consumption and is therefore suitable to
be scaled to fit the barrel of a pen. An exhaustive comparison
between the proposed system and a lab instrument proves that the
presented approach obtains comparable performances in terms
of sensitivity and resolution with the ones obtained by expensive
commercial instrumentation, meanwhile, the results show a 95 %
power consumption reduction and a 92 % area decrease w.r.t.
previously presented implementation.
Index Terms—Anaesthesia, bio-inspired, biosensor, portable,
quasi digital, therapeutic drug monitoring.
I. INTRODUCTION
The anaesthesia is a critical surgery medical procedure that
requires the administration of several drugs: typically, hyp-
notic, analgesic, and muscle relaxant. To obtain appropriate se-
dation and avoid intoxication, the delivery of these compounds
must be balanced and accurate. The Depth Of Anaesthesia
(DOA) is the metric to express the effect of anaesthesia on
the patient and it is nowadays evaluated by the estimation of
the Bispectral Index (BIS), which is a weighted sum of several
ElectroEncephaloGraphic (EEG) parameters [1]. However, this
approach presents some limitations and can lead to wrong
dose estimation due to the high inter-patient variability [2]. To
improve the traditional approach of anaesthesia delivery, this
work aims to present a Therapeutic Drug Monitoring (TDM)
system able to provide on-line monitoring of the actual drug
concentration infused in the patient’s veins. This will allow a
dynamic and personalised adjustment of the drug delivery [3].
Electrochemical investigation can be adopted to measure
the therapeutic compounds, in particular, Cyclic Voltammetry
This work is supported by Politecnico di Torino and Compagnia di San
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(CV) and Differential Pulse Voltammetry (DPV) [4] are highly
attractive method due to fast measurements, multi-sensing, and
high sensitivity [5]. In voltammetry, a voltage sweep is applied
to an electrochemical cell across its Working Electrode (WE)
and its Reference Electrode (RE). The applied potential makes
a Redox reaction to happen on the electrochemical sensor
and the current is then measured from the Counter Electrode
(CE). The resulting waveform (current upon applied voltage)
shows peaks, which give a reliable measure of the actual
drug concentration, and this can be done by systems called
potentiostats. Architectures able to monitor the anaesthetic
delivery have been recently presented, however, they are still
not easily integrable into portable or wearable devices [6], [7].
The focus of this paper is the design, development, and
validation of a Commercial-Off-the-Shelf (COTS) component-
based potentiostat, whose size is comparable with a pen. The
major design novelty of the proposed architecture is the amper-
ometric sensing through bio-inspired event-based techniques,
which is innovative with respect to the standard approach
involving power-hungry DAC and ADC in the architecture [8].
Indeed, the full proposed potentiostat is a quasi-digital elec-
tronic interface. In the quasi-digital domain, the information
is coded in timing in a series of pulses, called events, con-
taining both the properties of analog and digital signals. This
event-based design approach presents indeed great advantages
considering the processing in the time domain [9], the noise-
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Fig. 1: Concept of the proposed system, the portable moni-
toring pen will provide in real-time the concentration of the
drugs infused in the patient under anaesthesia.
reduction, and the accuracy increase [10]. The compact read-
out circuit is reducing both size and power consumption,
the information translation is continuous, without information-
loss, with a lower transmission energy cost [11]. The literature
presents numerous examples of applications based on bio-
inspired and quasi-digital approaches [12]–[14], although, to
the best of our knowledge, they have never been integrated for
the scope of providing on-line monitoring of anaesthesia.
The proposed architecture has been validated by comparing
the measurement results with the ones achieved by a com-
mercial laboratory potentiostat. The acetaminophen (APAP)
is the benchmark drug since it is usually administered in
anaesthesiology [15].
II. THE CONCEPT
We propose here a small and portable object able to monitor
the anaesthetic within a pen-shape as shown in Fig. 1. The
object shall be considered as an additional instrument to give
the anaesthesiologist the ability to continuously monitor the
drug absorption in the patient. The system must contain an
electronic potentiostat (composed by a voltage driver and a
current read-out) and an electrochemical sensor for anaesthetic
sensing. Fig. 2 presents the developed prototype of the portable
pen. In 18 mm diameter plastic tube a custom Printed Circuit
Board (PCB) implements the proposed architecture, while a
commercial Screen-Printed Electrode (SPE) acts as an elec-
trochemical sensor for the APAP.
III. DESIGN AND IMPLEMENTATION
The presented bio-sensor electronic-interface relies on
quasi-digital to analog conversion, and vice-versa. Fig. 3
shows the proposed design which contains a voltage driver
(PWMtoV) and a current read-out (ItoQDE). The voltage
follower (VF) avoids current flow on the RE. The grounded
WE is the selected topology for the potentiostat architecture
since it minimises the number of components required [4].
The WE is connected to half-supply (1⁄2 VDD) to achieve both
dual-voltage driving and dual-current sensing (i.e. driving
and measuring both positive and negative voltages/currents)
without the introduction in the system of a dual-voltage supply.
To drive the electrochemical cell a Pulse Width Modulated
(PWM) signal (which is indeed a type of q.d. signal) is
converted to a stable voltage by the PWMtoV. This block is a
second-order active low-pass filter in the Sallen-Key configu-
ration. The driving potential applied between the CE and the
SPE
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Pen Prototype
Fig. 2: Portable pen, the custom PCB implements the proposed
potentiostat and the SPE acts as electrochemical sensor.
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Fig. 3: Proposed potentiostat, the voltage driver (PWMtoV) and
the current read-out (ItoQDE) are both event-based modules.
WE is so directly proportional to the Duty Cycle (DC) of the
PWM input signal. At convenience, it is possible to furnish
to the electrochemical cell an increasing or decreasing voltage
ramp, just modulating the DC of the input. The oxidation or
reduction current (icell) is read converting it to a Quasi-Digital
stream of Event (QDE) by the ItoQDE block. Differently from
what the literature proposed in [12], [16], [17], we show here
a low-complexity one-input one-output read-out circuit able
to convert the dual-range current in an event stream, with a
single-voltage supply. The Fig. 4 shows the schematic of the
ItoQDE module which contains three amplifier blocks: a trans-
impedance (A1 and R1), an integrator (A2, R2, and C1) and
a comparator (A3, R4, and R5). Fig. 5 presents the timing
diagram of the current to frequency conversion. The capacitor
C1 is discharged according to the input current (adapted to the
dynamic by the trans-impedance amplifier), the comparator
notifies when VC1 overcomes the lower threshold, this sets
QDE. After that, a reference current rapidly charges again the
capacitor through the feedback MOSFET (M1 and R3), the
signal QDE is reset, and the conversion can start again. The
sampled current (icell) is proportional to the timing between
two consecutive edges according to (1), where i0 is the offset
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Fig. 4: Scheme of the ItoQDE converter. Current from the WE
(right) is converted to QDE train of pulses (left).
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Fig. 5: ItoQD converter timing diagram. The timing (T) of
QDE signal is proportional to the monitored current.
current and Vth is the comparator threshold.
icell = −R2 · C1 ·Vth
R1 · T + i0 (1)
In the implemented potentiostat the PCB size is 78×10 mm.
Tuning the component according to Eq. 1, the driving voltage
range is set to [– 1.2 : 1.2] V, while the input current range is
[– 60 : 60] µA. The system is designed to fit an input PWM
signal at the frequency of 20 kHz. In the current range, the
event rate (i.e. frequency of the events) of the output QDE
signal spans across [0.38 : 34] kevent/s, with a resting event
rate of 17 kevent/s. A closed feedback loop experiment is
performed to verify the system, inserting a resistor between
shortened CE-RE and WE nodes. Our experiments highlighted
that both PWM to voltage and current to QDE conversions are
linear with a maximum linearity error of 0.14 %. In order to
quantify the noise level, the WE input is left unconnected
and the current is sampled at the operating frequency of
the CV, namely 60 Hz. Considering the standard deviation
of the samples, the level of noise is 39 nA. In the full scale
(± 60 µA), the equivalent number of bits is 11.6 bit, closer to
the resolution of DAC usually implemented in a custom-built
potentiostat for bio-sensing application (12 bit [5]). The mean
total power consumption of the board measured during lab
testing is 19.5 mW.
IV. SYSTEM VALIDATION
As visible in Fig. 2, the potentiostat described in Section III
has been interfaced to the electrochemical sensor for the
APAP. This sensor has been obtained by carbon Screen-Printed
Electrode (SPE), namely DropSens DRP-110, with a central
carbon WE (4 mm diameter), carbon CE, and silver RE. To
perform the tests, APAP powder from Sigma Aldrich® is
dissolved in Phosphate Buffer Saline (PBS, pH 7.4, 10 mM).
The PBS is also used as background electrolyte. The measure
is performed on subsequent increasing concentration of APAP
in the therapeutic range [50 : 300] µM with an increase step of
50 µM. The measure is repeated three times for each condition
with a new electrode to consider the inter-electrode variability.
Two different electrochemical sensing methods are taken into
account: CV and DPV. The CV is performed with a Scan Rate
(SR) of 0.2 V/s, in the range [– 0.1 : 1.1] V, with a voltage step
of 6 mV, and a time step of 30 ms. The DPV is performed at
0.1 V/s, in the range [0 : 1] V, with a voltage step of 6 mV,
a time step of 60 ms, the modulation amplitude is set to
60 mV, and the modulation time to 30 ms. The difference in SR
between the two method is introduced in order to compensate
the higher sensitivity of DPV method [4]. An FPGA board
Xilinx® Artix-7TM controls the realised system. A custom-built
digital interface generates the PWM signal to drive the cell
with the waveform required by the voltammetry technique.
Measuring the timing of the event received on the QDE line
with a simple free-running counter, the current is constantly
sampled every voltage step. The data collected are sent out
through a UART-USB port and stored.
To validate our system, the sensing of APAP has been
also repeated by using a lab instrument, i.e. the Metrohm
Autolab PGSTAT 302N driven by the software Nova 1.11. The
data received both from the Autolab and from the developed
system are processed in Matlab® (v. R2017b), without any
further post-processing or filter. The peaks are detected with
the findpeaks built-in function, after a blank-baseline rigid
translation. The function returns prominence of the current
peak, this value is considered for the final estimation of the
drug concentration.
V. RESULTS
Fig.6 displays a comparison in the output acquired by the
two devices (our system and Autolab) considering CV (6a, 6b)
and DPV (6c, 6d). The proposed solution introduces a certain
level of white noise (6b, 6d), despite this, in both methods the
results are comparable. Fig. 7 reports the calibration curves
obtained by the analysis of the data. The implemented system
does not introduce a visible reduction in sensitivity, the two
fitting curves almost overlap with both methods. The evaluated
regression coefficient (r2, higher than 0.99) does not change,
hence, the system does not introduce non-linearities. Table I
presents a comparison between the two architectures. The
sensitivity is similar (-12 % w.r.t. Autolab in CV), with an
uncertain 20 % lower in the presented solution (w.r.t. Autolab
in DPV). Even if the Limit Of Detection (LOD, the minimum
detectable quantity of analyte, computed as three times the
standard deviation of the blank around the peak, divided by
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Fig. 6: Output voltammograms obtained by Autolab (left) and
by our system (right), considering CV (top) and DPV (bottom).
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Fig. 7: Calibration curves comparison between Autolab and
our system, for CV (a) and DPV (b).
TABLE I: Results comparison between Autolab and our sys-
tem, considering CV and DPV.
CV DPV
Autolab Our system Autolab Our system
Sensitivity
(nA/µM) 54.1± 7.1 47.5± 5.0 58.6± 5.9 57.6± 5.6
LOD (µM) 1.43± 0.18 5.43± 0.57 0.57± 0.06 5.08± 0.49
the sensitivity) has a higher value in our system, due to lower
noise rejection, the value remains one order of magnitude
lower than the minimum therapeutic concentration of the
APAP, hence, confirming its excellent performance. These
findings are highly promising, considering the reduction of
three orders of magnitude of hardware cost, the minimal
size, and the portability between our system under test and
the commercial instrumentation. The results prove that the
presented approach does not require the introduction of post-
processing, analog/digital filter, and differential measurement
in our system, methods all adopted by the Autolab, to get
comparable performance.
Table II shows a comparison between our solution and other
anaesthetic sensing circuits presented in literature [5], [7]. Our
system is suitable for the target application (as demonstrated
by the comparison w.r.t Autolab) with the advantage of re-
moving ADC and DAC, featuring 5 % of the power consumed
by [7] in 8 % of the size of [5].
VI. CONCLUSION
We presented a novel concept and newly-designed architec-
ture for drug monitoring targeted to be inserted in a portable
pen for improved anaesthesiology practice. The results prove
that our approach provides a portable, small, and low power
system (respectively 92 % and 95 % reduction w.r.t. previous
TABLE II: Comparison with anaesthetic sensing systems.
[5] [7] Our system
Conversion type ItoV ItoV ItoF
No of ADCs/DACs 2 2 0
Board size (mm2) 9600 n.a. 780
Power Consumption (mW) n.a. 390 19.5
implementations), always maintaining comparable sensitivity
with respect to reference commercial lab instrumentations, and
LOD one order of magnitude below the requested minimum
therapeutic concentration. Other anaesthetics, such as midazo-
lam and propofol are potentially detectable by this method,
therefore future works will test and validate performance in
monitoring these anaesthetics Moreover, the future steps are
the design of a full custom digital interface (optimised for the
bio-inspired event-based processing), and the development of
a needle-shaped bio-sensor.
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